Clinical Trial Update: Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This is a completed Phase 1/2 clinical trial evaluating fluphenazine in patients with refractory advanced multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Fluphenazine (fluphenazine)

Snippet

Sponsor: Immune Control | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: COMPLETED